{"status":"OK","data":{"advertisement":{"id":385423,"title":"ZAPYTANIE OFERTOWE VCT/CKD/20/2026 Badanie bezpiecze\u0144stwa TAS - Target Animal Safety Study","partial_offer_allowed":false,"publication_date":"2026-09-07","submission_deadline":"2026-09-14 23:59:59","planned_sign_date":"2026-09-01","supplementary_orders":"Zgodnie z zapytaniem ofertowym /according to the request for quotation.","terms_of_contract_change":"Zgodnie z zapytaniem ofertowym /according to the request for quotation.","created_at":"2026-09-07 19:13:31","modified_at":"2026-09-15 00:00:42","contact_persons":[{"id":61324,"forename":"Konrad","surname":"Szczukiewicz","phone_number":"+48514448784","email":"konrad@vetcelltech.com","created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":null},{"id":61325,"forename":"Marcin","surname":"Liwoch","phone_number":"+48515377337","email":"kontakt@vetcelltech.com","created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":null}],"orders":[{"id":624163,"estimated_value":null,"order_items":[{"id":701940,"description":"Wybrany Wykonawca odpowiedzialny b\u0119dzie za przeprowadzenie badania bezpiecze\u0144stwa stosowania produktu kom\u00f3rkowego na przewlek\u0142e zapalenie nerek (CKD, Chronic Kidney Disease) w gatunku docelowym (koty) - TARGET ANIMAL SAFETY STUDY zgodnie z wytycznymi VICH GL 43.\nW ramach zam\u00f3wienia wybrany Wykonawca odpowiedzialny b\u0119dzie za:\n1. wyb\u00f3r o\u015brodka/laboratorium GLP, przygotowanie dokumentacji i uzyskanie zgody komisji etycznej na przeprowadzenie badania TAS,\n2. uzgodnienie planu badania, \n3. przeprowadzenie badania w laboratorium GLP na terenie UE zgodnie z poni\u017cszymi za\u0142o\u017ceniami:\na. koty (rasa europejska), wiek 1- 3 lata, populacja na\u00efve lub non-na\u00efve,\nb. 3 grupy badane po 8 osobnik\u00f3w (24 koty) zale\u017cnie od testowanej dawki, podanie do\u017cylne \nproduktu kom\u00f3rkowego (2 razy), zapewnienie rezerwowej puli (4 koty),\nc. czas trwania badania ok. 120 dni (w tym obserwacja ok. 90 dni po ostatnim podaniu),\nd. obserwacja stanu zdrowia (\u015bmiertelno\u015b\u0107/zachorowalno\u015b\u0107) - 1 x dziennie,\ne. og\u00f3lne badanie weterynaryjne/kliniczne w tym min. zmiany w sk\u00f3rze, sier\u015bci, oczach, b\u0142onie \u015bluzowej, uk\u0142adzie kr\u0105\u017cenia, o\u015brodkowym uk\u0142adzie nerwowym, temperaturze cia\u0142a i wzorcach zachowania \u2013 1 dziennie,\nf. obserwacja miejsca wstrzykni\u0119cia \u2013 1 x dziennie,\ng. pomiar spo\u017cycia pokarmu i ocena ka\u0142u \u2013 1 x dziennie,\n h. pomiar masy cia\u0142a \u2013 1 x tydzie\u0144,\ni. badania laboratoryjne krwi \u2013 w 4 punktach czasowych\n ii. hematologia i koagulacja\n iii. biochemia\nj. analiza moczu - w 4 punktach czasowych\nk. pobranie, zabezpieczenie pr\u00f3bek krwi w celu sprawdzenia odpowiedzi immunologicznej zwierz\u0119cia i przekazanie Zamawiaj\u0105cemu (podmiotowi wskazanemu przez Zamawiaj\u0105cego) \u2013 w 4 punktach czasowych.\n4. w\u0142a\u015bciwe zarz\u0105dzanie produktem kom\u00f3rkowym (transport i monitorowanie warunk\u00f3w przechowywania i wydania),\n5. sta\u0142y kontakt z o\u015brodkiem badawczym,\n6. monitorowanie zgodno\u015bci z protoko\u0142em w o\u015brodku (na pocz\u0105tku i na ko\u0144cu badania)\n7. sta\u0142y kontakt ze sponsorem badania,\n8. opracowanie raportu ko\u0144cowego, w tym weryfikacja raportu z badania przez Zamawiaj\u0105cego (2 razy).\n\nZamawiaj\u0105cy zastrzega sobie prawo opcji. Uruchomienie prawa opcji lub jego cz\u0119\u015bci zale\u017cy wy\u0142\u0105cznie od woli Zamawiaj\u0105cego (uzale\u017cnionej w szczeg\u00f3lno\u015bci od zalece\u0144 Komisji Etycznej, decyzji lekarza weterynarii/prowadz\u0105cego badanie wynikaj\u0105cej ze stanu zwierz\u0105t oraz decyzji Zamawiaj\u0105cego wynikaj\u0105cej z przebiegu i wynik\u00f3w prac) i stanowi jego uprawnienie, a nie obowi\u0105zek.\nUruchomienie opcji nast\u0105pi poprzez pisemne zlecenie przekazane Wykonawcy.\n\nNieskorzystanie przez Zamawiaj\u0105cego z prawa opcji w ca\u0142o\u015bci lub w cz\u0119\u015bci nie daje Wykonawcy podstaw do wysuwania jakichkolwiek roszcze\u0144 (w tym roszcze\u0144 odszkodowawczych lub o zap\u0142at\u0119) z tytu\u0142u niezrealizowania zakresu opcjonalnego.\nW ramach prawa opcji Zamawiaj\u0105cy przewiduje mo\u017cliwo\u015b\u0107 zlecenia element\u00f3w dodatkowych opisanych w zapytaniu ofertowym.\n\nZam\u00f3wienie winno zosta\u0107 zrealizowane zgodnie z najwy\u017cszymi standardami \u015brodowiskowymi, zapewniaj\u0105cymi minimalizacj\u0119 zu\u017cycia materia\u0142\u00f3w, surowc\u00f3w i energii.\nMiejsce realizacji zam\u00f3wienia: wskazane przez Wykonawc\u0119.\nZamawiaj\u0105cy zobowi\u0105zuje si\u0119 do pokrycia koszt\u00f3w wszystkich bada\u0144 i procedur uznanych przez lekarza prowadz\u0105cego za konieczne z medycznego punktu widzenia dla zapewnienia bezpiecze\u0144stwa pacjent\u00f3w, w szczeg\u00f3lno\u015bci finansowaniu podlegaj\u0105 procedury wymagane decyzj\u0105 Lokalnej Komisji Etycznej jako warunek dopuszczenia lub kontynuacji badania, a tak\u017ce dzia\u0142ania interwencyjne wynikaj\u0105ce z bie\u017c\u0105cego stanu zdrowia pacjent\u00f3w. Rozliczenia dokonywane b\u0119d\u0105 wy\u0142\u0105cznie na podstawie rzeczywi\u015bcie wykonanych \u015bwiadcze\u0144, potwierdzonych raportami zbiorczymi Wykonawcy.\n\nJe\u015bli w opisie przedmiotu zam\u00f3wienia wyst\u0119puj\u0105: nazwy konkretnego produktu, normy jako\u015bciowe, nazwy w\u0142asne, patenty, znaki towarowe, typy, standardy nale\u017cy to traktowa\u0107 jedynie jako pomoc w opisie przedmiotu zam\u00f3wienia. W ka\u017cdym przypadku dopuszczalne s\u0105 rozwi\u0105zania r\u00f3wnowa\u017cne pod wzgl\u0119dem funkcjonalno\u015bci, jako\u015bci. Je\u017celi w opisie przedmiotu zam\u00f3wienia wskazano jakikolwiek znak towarowy, patent czy pochodzenie - nale\u017cy przyj\u0105\u0107, \u017ce wskazane patenty, znaki towarowe, pochodzenie okre\u015blaj\u0105 parametry techniczne, eksploatacyjne, u\u017cytkowe, co oznacza, \u017ce Zamawiaj\u0105cy dopuszcza z\u0142o\u017cenie ofert w tej cz\u0119\u015bci przedmiotu zam\u00f3wienia o r\u00f3wnowa\u017cnych parametrach. Obowi\u0105zek wykazania r\u00f3wnowa\u017cno\u015bci spoczywa na Wykonawcy. W razie w\u0105tpliwo\u015bci, co do r\u00f3wnowa\u017cno\u015bci poszczeg\u00f3lnych element\u00f3w Zamawiaj\u0105cy wezwie Wykonawc\u0119 do z\u0142o\u017cenia dodatkowych wyja\u015bnie\u0144 lub dokument\u00f3w.\n\n\nThe selected Contractor will be responsible for conducting a safety study of the use of the stem cell product for chronic kidney disease (CKD) in the target species (cats) - TARGET ANIMAL SAFETY STUDY in accordance with the VICH GL 43 guidelines.\n\nAs part of the contract, the selected Contractor will be responsible for:\n1. selection of a GLP centre/laboratory in the EU, preparation of documentation and obtaining the consent of the ethics committee to conduct the TAS study,\n2. agreement on the study plan,\n3. conducting the test in a GLP laboratory in accordance with the following assumptions:\na. cats (European breed), age 1-3 years, na\u00efve lub non-na\u00efve population,\nb. 3 test groups of 8 individuals (24 cats) depending on the tested dose, intravenous administration,\n stem cell product (2 times), provision of a reserve pool (4 cats),\nc. study duration: approximately 120 days (including observation for approximately 90 days after the last administration),\nd. health monitoring (mortality/morbidity) - 1 x daily,\ne. general veterinary/clinical examination including, but not limited to, changes in the skin, fur, eyes, mucous membranes, circulatory system, central nervous system, body temperature and behaviour pattern \u2013 1 per day,\nf. injection site observation \u2013 1 x daily,\ng. food intake measurement and stool assessment \u2013 1 x daily,\n h. body weight measurement \u2013 1 x week,\ni. laboratory blood tests \u2013 at 4 time points\n ii. hematology and coagulation\n iii. biochemistry\nj. urine analysis - at 4 time points,\nk. collection and securing of blood samples to check the animal\u2019s antibody response and delivery to the Ordering Party (entity indicated by the Ordering Party) \u2013 at 4 time points.\n4. proper management of the cell product (transport and monitoring of storage and release conditions),\n5. regular contact to the study centre,\n6. protocol compliance monitoring at site (at the beginning and end of the study)\n7. regular contact with the sponsor,\n8. preparation of the final report, with two reviews by the Ordering Party.\n\nThe Ordering Party reserves the right of option. Activation of this right, or any part thereof, depends solely on the Ordering Party's discretion (dependent in particular on the recommendations of the Ethics Committee, the decision of the veterinarian/examiner based on the condition of the animals, and the Ordering Party's decision based on the course and results of the work) and constitutes its right, not an obligation.\nThe option will be activated by means of a written order submitted to the Contractor.\nFailure by the Ordering Party to exercise the option right in whole or in part shall not give the Contractor any basis for making any claims (including claims for damages or payment) for failure to implement the optional scope.\nUnder the option right, the Ordering Party provides for the possibility of ordering the additional elements according to requst for quotation.\nThe order must be completed in accordance with the highest environmental standards, ensuring minimal consumption of materials, raw materials and energy.\nPlace of execution of the order: indicated by the Contractor.\nThe Client undertakes to cover the costs of all tests and procedures deemed medically necessary by the attending physician to ensure patient safety. In particular, funding will be provided for procedures required by the Local Ethics Committee as a condition for admission or continuation of the study, as well as interventions resulting from the current health status of patients. Payments will be made solely based on services actually performed, as confirmed by the Contractor's summary reports.\n\nIf the description of the subject of the contract includes specific product names, quality standards, proprietary names, patents, trademarks, types, or standards, these shall be treated solely as an aid in describing the subject of the contract. In all such cases, solutions equivalent in terms of functionality and quality are acceptable. If the description of the subject of the contract indicates any trademark, patent, or origin, it shall be understood that the indicated patents, trademarks, or origin define technical, operational, and functional parameters, meaning that the Ordering Party allows the submission of offers including equivalent parameters within this part of the subject of the contract. The Contractor is responsible for demonstrating equivalence. In case of doubts regarding the equivalence of specific elements, the Ordering Party may request the Contractor to submit additional explanations or documents.\n\n\nZamawiaj\u0105cy przed\u0142u\u017cy\u0142 termin sk\u0142adania ofert do 14.09.2026 r. i wprowadzi\u0142 zmiany do tre\u015bci Zapytania ofertowego Nr VCT/CKD/20/2026 - Zmiana nr 1 z dnia 07.09.2026 r.\nThe Ordering Party extended the deadline for submitting offers to September 14, 2026 and introduced changes to the Request for Proposals No. VCT/CKD/20/2026 - Amendment No.1 of September 7, 2026.","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"},{"id":8518,"code":"73200000-4","name":"Us\u0142ugi doradcze w zakresie bada\u0144 i rozwoju"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":null,"poviat":null,"commune":null,"locality":null,"created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:14:16","modified_by":null,"id":799677,"type":{"id":2,"name":"ca\u0142a Polska"},"group_uuid":"b4212fe6-6efc-4d95-8af7-6392824bad76"}],"participation_conditions":[{"id":2008781,"description":"Zamawiaj\u0105cy wymaga, aby oferta zawiera\u0142a:\n1. Formularz ofertowy zgodnie z Za\u0142\u0105cznikiem nr 1 do zapytania ofertowego,\n2. O\u015bwiadczenia wynikaj\u0105ce z pkt III zapytania ofertowego i zgodnie z Za\u0142\u0105cznikiem nr 1 do zapytania ofertowego,\n3. Pe\u0142nomocnictwo do wyst\u0119powania w imieniu Wykonawcy (je\u017celi dotyczy).\n\nThe Ordering Party requires that the offer must include:\n1. Proposal Form prepared in accordance with Appendix No. 1 to the request for proposal,\n2. Statements resulting from the provisions of point III of the requests for proposal,\n3. Power of attorney to act on behalf of the Contractor (if applicable).","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":null,"group_uuid":"626ed5b0-3c70-43bc-803e-a25b855aedb9"},{"id":2008782,"description":"Wykonawca posiada wiedz\u0119 i do\u015bwiadczenie umo\u017cliwiaj\u0105c\u0105 poprawn\u0105 realizacj\u0119 zam\u00f3wienia tj.:\n - do\u015bwiadczenie w przygotowaniu, zarz\u0105dzaniu i monitorowaniu bada\u0144 przedklinicznych zgodnie z GLP,\n- do\u015bwiadczenie i potencja\u0142 techniczny wykorzystania systemu Electronic Data Capture (lub r\u00f3wnowa\u017cny) do gromadzenia i przetwarzania danych pacjent\u00f3w uczestnicz\u0105cych w badaniu klinicznym,\n- do\u015bwiadczenie w przeprowadzaniu przynajmniej jednego badania TAS (Target Animal Safety) na zwierz\u0119tach towarzysz\u0105cych np. kotach, psach.\nWeryfikacja nast\u0105pi w oparciu o o\u015bwiadczenie Wykonawcy, zawarte w Za\u0142\u0105czniku nr 1 \u201cFormularz ofertowy\u201d.\n\nThe Contractor has the knowledge and experience necessary to properly perform the contract, i.e.:\n - experience in the preparation, management and monitoring of preclinical studies conducted in accordance with GLP (Good Laboratory Practice),\n- experience and technical potential in operating an Electronic Data Capture (EDC) system (or equivalent) for collecting and processing patient data in clinical trial,\n- experience in successfully conducting at least one TAS study on companion animals (e.g. cats, dogs).\n\nVerification will be based on the Contractor's statement, included in Appendix No.1 \"Proposal Form\".","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":null,"group_uuid":"39d277f5-6ee4-4d20-a81d-11fd3ad84a12"},{"id":2008783,"description":"Posiadania sytuacji ekonomicznej lub finansowej zapewniaj\u0105cej prawid\u0142ow\u0105 realizacj\u0119 zam\u00f3wienia, w szczeg\u00f3lno\u015bci nie znajduje si\u0119 w stanie upad\u0142o\u015bci, restrukturyzacji lub likwidacji.\nWeryfikacja nast\u0105pi w oparciu o o\u015bwiadczenie Wykonawcy, \u017ce znajduje si\u0119 w sytuacji ekonomicznej lub finansowej zapewniaj\u0105cej prawid\u0142ow\u0105 realizacj\u0119 zam\u00f3wienia, w szczeg\u00f3lno\u015bci nie znajduje si\u0119 w stanie upad\u0142o\u015bci, restrukturyzacji lub likwidacji, zawarte w Za\u0142\u0105czniku nr 1 \u201cFormularz ofertowy\u201d.\n\nHaving an economic or financial situation that ensures the proper execution of the order, in particular it is not in a state of bankruptcy, restructuring or liquidation.\nVerification will be based on the Contractor's statement that they are in an economic or financial situation that ensures the proper execution of the order, included in Appendix No. 1 \"Proposal Form\".","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":null,"group_uuid":"ecbd8a3c-d812-4e3d-8fd1-3dab1e5f6b4c"},{"id":2008784,"description":"1. Zakaz konfliktu interes\u00f3w\nZam\u00f3wienie nie mo\u017ce zosta\u0107 udzielone podmiotom powi\u0105zanym osobowo lub kapita\u0142owo z Zamawiaj\u0105cym.\nPrzez powi\u0105zania kapita\u0142owe lub osobowe rozumie si\u0119 wzajemne powi\u0105zania mi\u0119dzy beneficjentem lub osobami upowa\u017cnionymi do zaci\u0105gania zobowi\u0105za\u0144 w imieniu beneficjenta lub osobami wykonuj\u0105cymi w imieniu beneficjenta czynno\u015bci zwi\u0105zane z przeprowadzeniem procedury wyboru wykonawcy a wykonawc\u0105, polegaj\u0105ce w szczeg\u00f3lno\u015bci na:\na) uczestniczeniu w sp\u00f3\u0142ce jako wsp\u00f3lnik sp\u00f3\u0142ki cywilnej lub sp\u00f3\u0142ki osobowej, posiadaniu co najmniej 10% udzia\u0142\u00f3w lub akcji (o ile ni\u017cszy pr\u00f3g nie wynika z przepis\u00f3w prawa), pe\u0142nieniu funkcji cz\u0142onka organu nadzorczego lub zarz\u0105dzaj\u0105cego, prokurenta, pe\u0142nomocnika,\nb) pozostawaniu w zwi\u0105zku ma\u0142\u017ce\u0144skim, w stosunku pokrewie\u0144stwa lub powinowactwa w linii prostej, pokrewie\u0144stwa lub powinowactwa w linii bocznej do drugiego stopnia, lub zwi\u0105zaniu z tytu\u0142u przysposobienia, opieki lub kurateli albo pozostawaniu we wsp\u00f3lnym po\u017cyciu z wykonawc\u0105, jego zast\u0119pc\u0105 prawnym lub cz\u0142onkami organ\u00f3w zarz\u0105dzaj\u0105cych lub organ\u00f3w nadzorczych wykonawc\u00f3w ubiegaj\u0105cych si\u0119 o udzielenie zam\u00f3wienia,\nc) pozostawaniu z wykonawc\u0105 w takim stosunku prawnym lub faktycznym, \u017ce istnieje uzasadniona w\u0105tpliwo\u015b\u0107 co do ich bezstronno\u015bci lub niezale\u017cno\u015bci w zwi\u0105zku z post\u0119powaniem o udzielenie zam\u00f3wienia.\nWeryfikacja nast\u0105pi w oparciu o o\u015bwiadczenie Wykonawcy o braku powi\u0105za\u0144 kapita\u0142owych i/lub osobowych, zawarte w Za\u0142\u0105czniku nr 1 \u201cFormularz ofertowy\u201d.\n\n\nCapital or personal connections are understood as mutual connections between the Ordering Party or persons authorized to incur obligations on behalf of the Ordering Party, or persons performing activities related to the preparation and conduct of the contractor selection procedure on behalf of the Ordering Party, and the Contractor, particularly consisting of:\na) participating in a company as a partner in a civil partnership or partnership, holding at least 10% of shares or stocks, unless a lower threshold is stipulated by law, serving as a member of a supervisory or management body, proxy, or representative,\nb) being in a marital relationship, in a lineal kinship or affinity relationship up to the second degree, or a connection due to adoption, guardianship, or custody, cohabiting with the Contractor, their legal representative, or members of the management or supervisory bodies of Contractors applying for the contract,\nc) having a legal or factual relationship with the Contractor that raises reasonable doubts about impartiality or independence in connection with the procurement procedure.\nVerification will be based on the Contractor's statement of no capital and/or personal ties, included in Appendix No.1 \"Proposal Form\".\n\n2.Zam\u00f3wienie nie mo\u017ce zosta\u0107 udzielone w sytuacji wyst\u0105pienia konfliktu interes\u00f3w, z naruszeniem r\u00f3wnego traktowania wykonawc\u00f3w lub w spos\u00f3b prowadz\u0105cy do zak\u0142\u00f3cenia konkurencji. Zgodnie z definicj\u0105 wskazan\u0105 w \"Wytycznych dotycz\u0105cych kwalifikowalno\u015bci wydatk\u00f3w na lata 2021-2027\" konflikt interes\u00f3w oznacza ka\u017cd\u0105 sytuacj\u0119, w kt\u00f3rej osoby bior\u0105ce udzia\u0142 w przygotowaniu lub prowadzeniu post\u0119powania o udzielenie zam\u00f3wienia lub mog\u0105ce wp\u0142yn\u0105\u0107 na wynik tego post\u0119powania maj\u0105, bezpo\u015brednio lub po\u015brednio, interes finansowy, ekonomiczny lub inny interes osobisty, kt\u00f3ry postrzega\u0107 mo\u017cna jako zagra\u017caj\u0105cy ich bezstronno\u015bci i niezale\u017cno\u015bci w zwi\u0105zku z post\u0119powaniem o udzielenie zam\u00f3wienia\u201d.\nThe contract may not be awarded in a situation of conflict of interests, in breach of the equal treatment of contractors or in a way that leads to distortion of competition. According to the definition given in the \"Guidelines on the eligibility of expenditure for the years 2021-2027\", a conflict of interests means any situation in which persons involved in the preparation or conduct of the procurement procedure or who may influence the outcome of this procedure have, directly or indirectly, a financial, economic or other personal interest that may be perceived as compromising their impartiality and independence in connection with the procurement procedure.\n\n3. Wykluczeniu z post\u0119powania podlegaj\u0105 Wykonawcy, kt\u00f3rych oferty s\u0105 niekompletne i nie zawieraj\u0105 dokument\u00f3w i o\u015bwiadcze\u0144 wymaganych zgodnie z pkt III i IV zapytania ofertowego.\nContractors whose offers are incomplete and do not contain statements required in points III and IV are subject to exclusion from the procedure.\n\n4. Z udzia\u0142u w post\u0119powaniu wykluczone s\u0105 r\u00f3wnie\u017c podmioty, w stosunku do kt\u00f3rych zachodz\u0105 okoliczno\u015bci opisane w art. 7 ust. 1 ustawy z dnia 13 kwietnia 2022 r. o szczeg\u00f3lnych rozwi\u0105zaniach w zakresie przeciwdzia\u0142ania wspieraniu agresji na Ukrain\u0119 oraz s\u0142u\u017c\u0105cych ochronie bezpiecze\u0144stwa narodowego\nEntities are also excluded from participation in the proceedings if the circumstances apply as defined under Article 7 section 1 of the Act of 13 April 2022 on special solutions to prevent support for the aggression against Ukraine and to protect national security.\n\nWeryfikacja nast\u0105pi w oparciu o o\u015bwiadczenie Wykonawcy, zawarte w Za\u0142\u0105czniku nr 1 \u201cFormularz ofertowy\u201d.\nVerification will be based on the Contractor's statement, included in Appendix No. 1 \"Proposal Form\".","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":null,"group_uuid":"3e530b74-8924-462d-87e7-d3eb4de9139e"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:14:16","modified_by":null,"group_uuid":"188c6820-b1ac-4745-a440-c54429bc3b27"}],"evaluation_criteria":[{"id":1126092,"price_criterion":true,"description":"Cena netto / Price net - 100%","created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":null,"group_uuid":"a672cec7-fd3f-406d-ada9-43a866481511"}],"is_variant":false,"title":"Target animal safety study","order_node":{"id":439179},"created_by":null,"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:14:16","modified_by":null}],"created_by":{"id":61112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"VET CELL TECH sp\u00f3\u0142ka z ograniczon\u0105 odpowiedzialno\u015bci\u0105","identification_number_type":"nip","identification_number":"6762639198","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":{"id":61112,"contact_persons":[]},"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":{"id":61112,"contact_persons":[]},"id":1092150,"street":"Profesora Micha\u0142a Bobrzy\u0144skiego","number_description":"14","postcode":"30-348"},"created_by":{"id":61112,"contact_persons":[]},"created_at":"2026-09-07 19:13:31","modified_at":"2026-09-07 19:13:31","modified_by":{"id":61112,"contact_persons":[]},"id":386465},"advertisement":{"id":272081,"number":"2026-61112-272081","publication_date":"2026-08-04","created_by":{"id":61112,"contact_persons":[]},"created_at":"2026-04-02 14:53:35","modified_at":"2026-09-15 00:00:42","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[359176,385423],"enrollment":null,"projects":[{"id":51253,"name":"\u201eOpracowanie globalnie innowacyjnego leku weterynaryjnego na przewlek\u0142e zapalenie nerek u kot\u00f3w, opartego o allogeniczne kom\u00f3rki macierzyste oraz wdro\u017cenie produkcji w warunkach stand. farmaceut. GMP","number":"0299/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-23 09:41:01","modified_at":"2023-02-23 09:41:01","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-23 10:43:43","modified_at":"2023-02-23 10:43:43","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FEMP.01.01-IP.01-0299/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-23 09:39:27","modified_at":"2023-02-23 09:39:27","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-23 09:39:44","modified_at":"2023-02-23 09:39:44","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":61112,"contact_persons":[]},"created_at":"2024-10-15 15:09:35","modified_at":"2024-10-15 15:09:35","modified_by":{"id":61112,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":359176,"publication_date":"2026-08-04"},"id":2690828,"name":"ZAPYTANIE OFERTOWE VCT/CKD/20/2026","file":{"id":2987043,"name":"VCT_CKD_20_2026_ZapytanieOfertowe_TAS.pdf","created_at":"2026-09-07 19:13:31","created_by":{"forename":"Konrad","surname":"Szczukiewicz"},"uri":"/api/files/2987043"},"group_uuid":"51c2743c-3683-4bef-8698-bea8d886e948"},{"origin":{"id":359176,"publication_date":"2026-08-04"},"id":2690829,"name":"Za\u0142\u0105cznik 1 - FORMULARZ OFERTOWY VCT/CKD/20/2026","file":{"id":2987044,"name":"VCT_CKD_20_2026_ZapytanieOfertowe_TAS_Zalcznik1_FO.pdf","created_at":"2026-09-07 19:13:31","created_by":{"forename":"Konrad","surname":"Szczukiewicz"},"uri":"/api/files/2987044"},"group_uuid":"141cd810-1e0e-46e2-aeb7-7d7cb4b9174d"},{"origin":{"id":359176,"publication_date":"2026-08-04"},"id":2690830,"name":"REQUEST FOR QUOTATION VCT/CKD/20/2026","file":{"id":2987046,"name":"VCT_CKD_20_2026_TAS_RequestForQuotation.pdf","created_at":"2026-09-07 19:13:31","created_by":{"forename":"Konrad","surname":"Szczukiewicz"},"uri":"/api/files/2987046"},"group_uuid":"132f6e28-ca4e-40c1-8ce4-c3433453354d"},{"origin":{"id":359176,"publication_date":"2026-08-04"},"id":2690831,"name":"Appendix No. 1 - PROPOSAL FORM VCT/CKD/20/2026","file":{"id":2987049,"name":"VCT_CKD_20_2026_TAS_ProposalForm.pdf","created_at":"2026-09-07 19:13:31","created_by":{"forename":"Konrad","surname":"Szczukiewicz"},"uri":"/api/files/2987049"},"group_uuid":"4afdb8d7-a0f5-4bee-a04b-f56b88802fbe"},{"origin":{"id":385423,"publication_date":"2026-09-07"},"id":2754765,"name":"ZAPYTANIE OFERTOWE VCT/CKD/20/2026 - Zmiana nr 1","file":{"id":3057595,"name":"VCT_CKD_20_2026_ZapytanieOfertowe_TAS_zad3_Zmiana1.pdf","created_at":"2026-09-07 19:12:26","created_by":{"forename":"Konrad","surname":"Szczukiewicz"},"uri":"/api/files/3057595"},"group_uuid":"c4cbb3fe-2fec-45fe-bd60-73fb2ca504dd"},{"origin":{"id":385423,"publication_date":"2026-09-07"},"id":2754766,"name":"REQUEST FOR QUOTATION VCT/CKD/20/2026 - Amendment No.1","file":{"id":3057597,"name":"VCT_CKD_20_2026_TAS_RequestForQuotation_Amendment1.pdf","created_at":"2026-09-07 19:12:31","created_by":{"forename":"Konrad","surname":"Szczukiewicz"},"uri":"/api/files/3057597"},"group_uuid":"76172a8e-f5a0-4af1-9485-7fe806b0fd18"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}